Dacarbazine alone or associated with melanoma‐bearing cancer pain model induces painful hypersensitivity by TRPA1 activation in mice-Reference-Cited by-同舟云学术

Dacarbazine alone or associated with melanoma‐bearing cancer pain model induces painful hypersensitivity by TRPA1 activation in mice

Published:2020-05-15 Issue:10 Volume:146 Page:2797-2809
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Brusco Indiara¹,Li Puma Simone²,Chiepe Kelly Braga³,Silva Brum Evelyne¹,David Antoniazzi Caren Tatiane⁴,Almeida Amanda Spring⁴,Camponogara Camila¹,Silva Cássia Regina⁵,De Logu Francesco²,Andrade Vanessa Moraes³,Ferreira Juliano⁶,Geppetti Pierangelo²,Nassini Romina²,Oliveira Sara Marchesan¹,Trevisan Gabriela³⁴^ORCID

Affiliation:

1. Graduate Program in Biological Sciences: Biochemistry Toxicology, Center of Natural and Exact SciencesFederal University of Santa Maria Santa Maria Brazil

2. Department of Health SciencesUniversity of Florence Florence Italy

3. Graduate Program in Health ScienceUniversity of the Extreme South of Santa Catarina—Unesc Criciúma Brazil

4. Graduate Program in Physiology and Pharmacology, Health Sciences CenterFederal University of Santa Maria Santa Maria Brazil

5. Graduate Program in Genetics and Biochemistry, Biotechnology InstituteFederal University of Uberlandia Uberlandia Brazil

6. Graduate Program in PharmacologyFederal University of Santa Catarina Florianopolis Brazil

Funder

Associazione Italiana per la Ricerca sul Cancro

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32648

Reference47 articles.

1. Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis

2. In-vitro and in-vivo inhibition of melanoma growth and metastasis by the drug combination of celecoxib and dacarbazine

3. Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine

4. Role of EIF5A2, a downstream target of Akt, in promoting melanoma cell invasion

5. Cancer treatment and survivorship statistics, 2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological agents targeting transient receptor potential (TRP) channels in neuropathic pain: Preclinical and clinical status;European Journal of Pharmacology;2024-10

2. Transient Receptor Potential (TRP) channels in cancer: Implications for drug discovery and development;TRP Channels as Therapeutic Targets;2024

3. Chromatographic method for dacarbazine quantification in skin permeation experiments;Journal of Pharmaceutical and Biomedical Analysis;2023-09

4. Elsinochrome A induces cell apoptosis and autophagy in photodynamic therapy;Journal of Cellular Biochemistry;2023-08-09

5. Research Progress on TRPA1 in Diseases;The Journal of Membrane Biology;2023-04-11